Advertisement


Drugs Controller General Of India
India  /  Published 26.04.22

Covaxin nod for kids aged 6-12

India's drug regulator has granted emergency use authorisation for Biological E's COVID-19 vaccine Corbevax for those aged five to 12 years and Bharat Biotech's Covaxin for children in the...
By Our Bureau, Agencies in New Delhi

India  /  Published 22.04.22

Plan to clear jab for 5-11 kids

Chennai: The Tamil Nadu government will grant 270 days’ leave to women employees and teachers to care for their children got through surrogacy. PTI ...
By PTI in New Delhi

Opinion  /  Published 11.04.22

Head: Letters to the Editor: How Bengalis have 'adopted' the once exotic 'phulkopi'

Flower power Sir — There will be few Bengalis who can imagine their lives without the cauliflower. Be it in machher jhol or shingara, the phulkopi is an inseparable pa...
By The Telegraph

India  /  Published 06.03.22

Covovax: Govt proposes consent for phase-3

An expert panel of India's central drug authority has recommended permission for conducting a phase-3 clinical trial of Covid vaccine Covovax as a booster dose in adults, official sources said on ...
By Our Bureau, PTI in New Delhi

West Bengal  /  Published 25.11.21

Needle-free ZyCov-D in Covid battle soon

After Covaxin, Covishield and Sputnik V, a fourth vaccine, DNA-based vaccine ZyCov-D is likely to be in use from next month in Bengal. The Union health ministry assured the state on Wednesday that it...
By Snehamoy Chakraborty in Bolpur(Birbhum)

Advertisement

India  /  Published 15.11.21

SII to export 5 crore jabs

  The Indian government has permitted export of 5 crore doses of Covovax, a COVID-19 vaccine domestically produced here by the Serum Institute of India (SII), as the jab has not yet been approve...
By Payal Banerjee in New Delhi

India  /  Published 12.10.21

Covaxin gets expert panel nod for 2 to 18 age group

An expert panel of India's Central Drug Authority has recommended granting emergency use authorisation to Bharat Biotech's Covaxin for children in the 2 to 18 years age group with certain cond...
By Our Bureau, PTI in New Delhi

India  /  Published 05.10.21

Cadila: Nod for Covid jab trial

Drug firm Cadila Healthcare on Tuesday said it has received permission from the Indian drug regulator for conducting phase III trials for its two-dose COVID-19 vaccine ZyCoV-D. The company has alread...
By Our Bureau, PTI in New Delhi

India  /  Published 21.08.21

Vaccine: Nod to jab for 12-plus kids

India has approved a DNA vaccine against Covid-19 developed by the Ahmedabad-based pharmaceutical company Zydus Cadila, the country’s second homegrown vaccine against the infection and the first...
By G.S. Mudur in New Delhi

India  /  Published 11.07.21

India's vaccine drive not as bad as it looks

First the good news – and then a host of qualifications. India’s vaccination drive’s been a jerky stop-and-start affair but it’s closer to its targets than might have been expe...
By Paran Balakrishnan in New Delhi


Advertisement

Download our latest App

to get update on the go...

Advertisement

Advertisement
 
Copyright © 2020 The Telegraph. All rights reserved.